-
Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders.
McHugh RK, Hu M, Campbell ANC, Hilario EY, Weiss RD, Hien DA. Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. Journal of Traumatic Stress 2014;27(1):1-8.
-
Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.
Rieckmann TR, Abraham AJ, Kovas AE, McFarland BH, Roman PM. Impact of research network participation on the adoption of buprenorphine for substance abuse treatment. Addictive Behaviors 2014;39(5):889-896.
-
Alcohol, tobacco, and drug use among emergency department patients.
Sanjuan PM, Rice SL, Witkiewitz K, Mandler RN, Crandall C, Bogenschutz MP. Alcohol, tobacco, and drug use among emergency department patients. Drug and Alcohol Dependence 2014;138(1):32-38.
-
Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act.
Ghitza UE, Tai B. Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act. Journal of Health Care for the Poor and Underserved 2014;25(1 suppl):36-45.
-
Use of sexual risk assessment and feedback at intake to promote counselor awareness of subsequent client risk behavior during early treatment.
Hartzler B, Beadnell B, Calsyn DA. Use of sexual risk assessment and feedback at intake to promote counselor awareness of subsequent client risk behavior during early treatment. Substance Use & Misuse 2014;49(10):1270-1277.
-
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.
Winhusen TJ, Brigham GS, Kropp FB, Lindblad R, Gardin JG II, Penn PE, Hodgkins C, Kelly TM, Douaihy AB, McCann MJ, Love LD, DeGravelles E, Bachrach K, Sonne SC, Hiott R, Haynes LF, Sharma G, Lewis DF, VanVeldhuisen PC, Theobald J, Ghitza UE. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. Journal of Clinical Psychiatry 2014;75(4):336-343.
-
Not getting lost in translational science: A tool for navigating the pre-implementation phase of multi-site pharmacological clinical trials.
Winhusen TJ. Not getting lost in translational science: A tool for navigating the pre-implementation phase of multi-site pharmacological clinical trials. Applied Clinical Trials 2014;23:36-39
-
Clinically relevant characteristics associated with early treatment drug use versus abstinence.
Cochran G, Stitzer ML, Nunes EV, Hu M, Campbell ANC. Clinically relevant characteristics associated with early treatment drug use versus abstinence. Addiction Science & Clinical Practice 2014;9:6.
-
Internet-delivered treatment for substance abuse: A multisite randomized controlled trial.
Campbell ANC, Nunes EV, Matthews AG, Stitzer ML, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, VanVeldhuisen PC, Goldman B, Babcock D, Stabile PQ, Winhusen TJ, Ghitza UE. Internet-delivered treatment for substance abuse: A multisite randomized controlled trial. American Journal of Psychiatry 2014;171:683-690.
-
Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain.
Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller DL, Jacobs P, Gardin JG II, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain. Journal of Substance Abuse Treatment 2014;47(2):140-145.